Moderna 年度财报公司的唯一产品新冠疫苗收入360亿美金，交NIH下属的NIAID$4亿”Royalties“

Moderna Paid Fauci Lead Organization $400 Million in 'Royalties' on COVID-19 Vaccine Sales

So, Follow the Money, Not the Science!!!*****AnE2VSMCyz

— JoeBell ???????????????????????????????????????????? (@JoeBell) February 26, 2023

 

 

A Covid vaccine maker that received clinical trial approvals from the National Institute of Allergy and Infectious Disease (NIAID), formerly headed by Dr. Anthony Fauci, has just paid $400 million to the “public health” organization.

 

The “catch-up-payment” that Moderna recently paid the NIAID was reported by the industry watchdog group Fierce Pharma as well as by the New York Times.

 

“In Moderna’s earnings release Thursday, the company said it recently paid the National Institute of Allergy and Infectious Diseases (NIAID) a $400 million ‘catch-up payment’ under a new royalty-bearing license agreement between the parties,” Fierce Pharma noted.

“The payment is part of a license agreement between Moderna and NIAID inked late last year. With the deal, Moderna is paying the U.S. government to access ‘certain patent rights concerning stabilizing prefusion coronavirus spike proteins,'” the report added, citing Moderna Chief Financial Officer Jamie Mock.

 

Moderna agreed to pay NIAID “low single-digit royalties” on COVID-19 vaccine sales moving forward, Mock added.

 

https://trendingpoliticsnews.com/payday-knab/

 

 

https://investors.modernatx.com/news/news-details/2023/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2022-Financial-Results-and-Provides-Business-Updates/default.aspx